Inventor
ZHAI HAIXIAO
US39 patents
⚠️ This page may combine multiple inventors who share the name “ZHAI HAIXIAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CURIS INC
27 patentsUS8906909B2Dec 9, 2014
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CURIS INC17 citations92
US8367663B2Feb 5, 2013
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CURIS INC17 citations90
US10676482B2Jun 9, 2020
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CURIS INC3 citations84
US9249156B2Feb 2, 2016
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC6 citations84
US10336770B2Jul 2, 2019
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CURIS INC7 citations82
US9657032B2May 23, 2017
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC5 citations82
US10543197B2Jan 28, 2020
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC1 citations73
US10428068B2Oct 1, 2019
Fused amino pyridine as HSP90 inhibitors
CURIS INC1 citations73
US9169244B2Oct 27, 2015
Tyrosine kinase inhibitors containing a zinc binding moiety
CURIS INC4 citations73
US8846912B2Sep 30, 2014
Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety
CURIS INC2 citations63
US7888361B2Feb 15, 2011
Tyrosine kinase inhibitors containing a zinc binding moiety
CURIS INC4 citations63
US7846938B2Dec 7, 2010
Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety
CURIS INC4 citations63
US11654136B2May 23, 2023
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC0 citations62
US11597732B2Mar 7, 2023
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CURIS INC0 citations62
US11560377B2Jan 24, 2023
Fused amino pyridine as HSP90 inhibitors
CURIS INC0 citations62
US11261195B2Mar 1, 2022
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CURIS INC0 citations62
US11135205B2Oct 5, 2021
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC0 citations62
US10894795B2Jan 19, 2021
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CURIS INC0 citations62
US10844056B2Nov 24, 2020
Fused amino pyridine as HSP90 inhibitors
CURIS INC0 citations52
US10214514B2Feb 26, 2019
Hedgehog antagonists having zinc binding moieties
CURIS INC0 citations52
US10035797B2Jul 31, 2018
Fused amino pyridine as HSP90 inhibitors
CURIS INC0 citations52
US9708299B2Jul 18, 2017
Hedgehog antagonists having zinc binding moieties
CURIS INC0 citations52
US9630965B2Apr 25, 2017
Fused amino pyridine as HSP90 inhibitors
CURIS INC0 citations52
US9402832B2Aug 2, 2016
Fused amino pyridine as HSP90 inhibitors
CURIS INC0 citations52
US9040556B2May 26, 2015
Fused amino pyridine as HSP90 inhibitors
CURIS INC0 citations52
US9024024B2May 5, 2015
Quinazoline based EGFR inhibitors containing a zinc binding moiety
CURIS INC0 citations52
US10111864B2Oct 30, 2018
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CURIS INC0 citations50
CAI XIONG
7 patentsUS8461157B2Jun 11, 2013
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
CAI XIONG27 citations95
US8710219B2Apr 29, 2014
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
CAI XIONG14 citations92
US8586605B2Nov 19, 2013
Fused amino pyridine as HSP90 inhibitors
CAI XIONG6 citations84
US8324240B2Dec 4, 2012
Fused amino pyridine as HSP90 inhibitors
CAI XIONG7 citations84
US8518910B2Aug 27, 2013
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
CAI XIONG2 citations62
US8119616B2Feb 21, 2012
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety
CAI XIONG3 citations62
US8426419B2Apr 23, 2013
Tyrosine kinase inhibitors containing a zinc binding moiety
CAI XIONG1 citations52